The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Al Jabal Al Akhdar named GCC Tourism Capital
- Syrian doctor’s stories at Brazil’s Book Biennial
- Real Madrid launches football program in Tunisia
- AIM: Arab Chamber calls for more digitalized trade
- Halal market continues to show its strength
- Syria opens tender for power equipment
- Qatar advances in education, OECD finds
- A Brazilian tax expert in Dubai
